vTv Therapeutics, Inc. (VTVT)
31.61
+1.15
(+3.78%)
USD |
NASDAQ |
Sep 17, 15:36
vTv Therapeutics 1 Year Total Returns (Daily) : 43.85% for Sept. 16, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 16, 2026 | 43.85% |
| September 15, 2026 | 49.24% |
| September 14, 2026 | 59.11% |
| September 11, 2026 | 59.37% |
| September 10, 2026 | 67.51% |
| September 09, 2026 | 77.36% |
| September 08, 2026 | 74.79% |
| September 04, 2026 | 79.88% |
| September 03, 2026 | 77.37% |
| September 02, 2026 | 81.52% |
| September 01, 2026 | 96.74% |
| August 31, 2026 | 97.04% |
| August 28, 2026 | 99.26% |
| August 27, 2026 | 102.0% |
| August 26, 2026 | 112.6% |
| August 25, 2026 | 111.9% |
| August 24, 2026 | 111.8% |
| August 21, 2026 | 121.9% |
| August 20, 2026 | 120.5% |
| August 19, 2026 | 112.0% |
| August 18, 2026 | 102.8% |
| August 17, 2026 | 102.8% |
| August 14, 2026 | 96.86% |
| August 13, 2026 | 119.9% |
| August 12, 2026 | 119.3% |
| Date | Value |
|---|---|
| August 11, 2026 | 113.5% |
| August 10, 2026 | 144.9% |
| August 07, 2026 | 150.9% |
| August 06, 2026 | 136.8% |
| August 05, 2026 | 135.3% |
| August 04, 2026 | 121.5% |
| August 03, 2026 | 122.2% |
| July 31, 2026 | 116.4% |
| July 30, 2026 | 118.6% |
| July 29, 2026 | 108.7% |
| July 28, 2026 | 100.0% |
| July 27, 2026 | 99.61% |
| July 24, 2026 | 80.45% |
| July 23, 2026 | 85.91% |
| July 22, 2026 | 85.97% |
| July 21, 2026 | 96.24% |
| July 20, 2026 | 93.08% |
| July 17, 2026 | 103.5% |
| July 16, 2026 | 90.05% |
| July 15, 2026 | 93.66% |
| July 14, 2026 | 90.78% |
| July 13, 2026 | 85.66% |
| July 10, 2026 | 91.37% |
| July 09, 2026 | 103.2% |
| July 08, 2026 | 116.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Spyre Therapeutics, Inc. | 515.2% |
| ACADIA Pharmaceuticals, Inc. | 14.94% |
| Alnylam Pharmaceuticals, Inc. | -48.11% |
| Anika Therapeutics, Inc. | 140.9% |
| Savara, Inc. | 41.32% |